Skip to main content

Table 1 Clinicopathological characteristics of the patients according to tomographic response (n= 53)

From: Kinetics of HE4 and CA125 as prognosis biomarkers during neoadjuvant chemotherapy in advanced epithelial ovarian cancer

Variable

Category

With response (%)

Non response (%)

pa

Body mass index (WHO)

Overweight

12 (37.5)

11 (52.4)

0.934

Normal

13 (40.6)

6 (28.6)

Obese

7 (21.9)

4 (19.0)

Diabetes mellitus

Yes

4 (12.5)

2 (9.5)

1.000

No

28 (87.5)

19 (90.5)

Systemic Arterial Hypertension

Yes

10 (31.2)

7 (33.3)

1.000

No

22 (68.8)

14 (66.7)

Smoking

Yes

6 (18.7)

2 (9.5)

0.335

No

26 (81.3)

19 (90.5)

ECOG

0-1

29 (90.6)

20 (95.2)

0.065

≥ 2

3 (9.4)

1 (4.8)

Histological subtype

Papillary serous

32 (100)

17 (81.0)

0.037

Endometrioid

0 (0.0)

3 (14.2)

Clear cell

0 (0.0)

1 (4.8)

Clinical stage (FIGO)

IVB

18 (56.3)

10 (47.6)

0.914

IVA

7 (21.9)

9 (42.9)

IIIC

5 (15.6)

2 (9.5)

IIIB

1 (3.1)

0 (0.0)

IIIA

1 (3.1)

0 (0.0)

  1. Data is presented as n (%)
  2. a X2 tests
  3. Those p values with statistical significance (less than 0.05) are marked in bold